Here are relevant reports on : ai-in-oncology-market
-
Latin America Enteral Feeding Devices Market by Type (Enteral Feeding, Nasogastric Tubes, Enteral Feeding Syringes, Nasal Feeding, Nasoduodenal), Insertion Method, Age Group (Adult, Pediatric), Application (Oncology, Hypermetabolism), End User - Forecast to 2032
The Latin America Enteral Feeding Devices market, valued at USD 0.24 billion in 2025, stood at USD 0.25 billion in 2026 and is projected to advance at a resilient CAGR of 5.2% from 2026 to 2032, culminating in a forecasted valuation of USD 0.34 billion by the end of the period. The increase in the market is due to the growing cases of chronic and acute diseases that are difficult to manage without long-term nutritional support.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Surgical Microscopes Market by Product Type (Devices, Accessories, Software), Application (Neuro and Spine Surgery, Plastic & Reconstructive Surgery, ENT Surgery, Oncology), End User (Hospital, Outpatient Facilities), and Region - Global Forecast to 2030
The global surgical microscopes market, valued at US$1.33 billion in 2024, stood at US$1.51 billion in 2025 and is projected to advance at a resilient CAGR of 11.4% from 2025 to 2030, culminating in a forecasted valuation of US$2.69 billion by the end of the period. The surgical microscopes market is set to grow, driven by emerging countries like India, Brazil, and Vietnam. These nations are experiencing rapid economic development, which is leading to a rising middle class with increasing disposable incomes.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Antibody Therapeutics Market by Format (Monoclonal, Polyclonal, Antibody Fragment, Bispecific), Disease Area (Oncology, Autoimmune & Inflammatory, Neurology, Hematology, Infectious), Source (Human, Chimeric), Route (IV, SC) & Region - Global Forecast to 2028
The global antibody therapeutics market, valued at US$217.6 billion in 2022, stood at US$247.3 billion in 2023 and is projected to advance at a resilient CAGR of 14.1% from 2023 to 2028, culminating in a forecasted valuation of US$479.0 billion by the end of the period. Growth in the antibody therapeutics market is mainly driven by factors such as growing advancements in antibody engineering for development of novel therapeutics, growing R&D activities among others
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Enteral Feeding Devices Market By Type (Enteral Feeding Tubes, Nasogastric Tubes, Enteral Feeding Syringes, Nasal Feeding Tubes), Insertion Method, Age Group (Adult, Pediatric), Application (Oncology, Hypermetabolism), End User - Global Forecast to 2032
The global enteral feeding devices market, valued at US$3.12 billion in 2024, stood at US$3.27 billion in 2025 and is projected to advance at a resilient CAGR of 5.5% from 2024 to 2032, culminating in a forecasted valuation of US$4.76 billion by the end of the period. Market growth is driven by the increasing geriatric population, technological advancements, regulatory support, greater awareness of nutritional needs, and expansion in emerging economies.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Asia Pacific Epigenetics Market by Offering [Enzymes, Kits & Reagents, Software, Services], Method [DNA Methylation, Histone Modification], Technique [NGS, PCR], Application [Oncology, Immunology, Developmental Biology], End User - Forecast to 2030
The Asia Pacific epigenetics market, valued at US$0.44 billion in 2024, stood at US$0.49 billion in 2025 and is projected to advance at a resilient CAGR of 14.6% from 2025 to 2030, culminating in a forecasted valuation of US$0.97 billion by the end of the period. The Asia Pacific epigenetics market is experiencing growth, driven by increasing demand for precise biomarker discovery and multi-omics research across oncology, immunology, and precision medicine programs.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Microcatheters Market by Type (Delivery, Diagnostic, Aspiration, Steerable), Design (Single, Dual), Application (Cardiovascular, Neurovascular, Peripheral Vascular, Oncology), End-User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2028
The global microcatheters market in terms of revenue was estimated to be worth $874 million in 2023 and is poised to reach $1,142 million by 2028, growing at a CAGR of 5.5% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Interventional Radiology Imaging Market by Product (MRI System, Ultrasound Imaging System, CT Scanner, Angiography System), Procedures (Angiography, Angioplasty, Biopsy) & Application (Cardiology, Oncology, Urology & Nephrology) - Global Forecast to 2021
The global interventional radiology imaging market is projected to grow at a CAGR of 6.7%. This market is segmented based on product, procedure, and application. A number of factors, such as rising incidence and prevalence of chronic diseases, increasing demand for minimally invasive procedures, technological advancements are expected to drive the growth of this market.
- Published: March 2017
- Price: $ 4950
- TOC Available:
-
Embolotherapy Market by Product (Embolic Agents (Microspheres, Liquid Embolic Agents, Coil), Microcatheters), Indication (Oncology, Vascular, Aneurysm, Urology, Nephrology), Procedure (TACE, TARE), Enduser (Hospital, Clinics, ASC) - Global Forecast to 2026
The global embolotherapy market boasts a total value of $3.4 billion in 2021 and is projected to register a growth rate of 8.0% to reach a value of $5.0 billion by 2026. The major players in the market include Boston Medical Corporation (US), Terumo Medical Systems (Japan), Medtronic (US), Johnson & Johnson (US), and Stryker Corporation (US). Other key players in the embolization therapy market include Sirtex Medical Limited (US), Abbott Laboratories (US), Acandis GmbH (Germany), Balt (France), Cook Medical (US), Kaneka Corporation (Japan), Penumbra, Inc. (US), Merit Medical Systems (US), Meril Life Sciences Pvt. Ltd. (India), Cardiva (US), Shape Memory Medical Inc. (US), Artio Medical Inc. (US), Rapid Medical (US), Emboline, Inc. (US), and IMbiotechnologies Ltd. (Canada), among others.
- Published: May 2021
- Price: $ 4950
- TOC Available:
-
Humanized Mouse and Rat Model Market by Type (Genetic Models, Cell-based Models, Rat Models), Application (Oncology, Immunology, Neuroscience, Toxicology, Infectious Diseases), End User (Pharma, Biotech), and Region - Global Forecast to 2030
The global humanized mouse and rat model market, valued at US$255.8M in 2024, is forecasted to grow at a 8.2% CAGR, reaching US$276.2M by 2025 and US$409.8M by 2030. The surge in the use of humanized models in drug discovery research, rising demand for personalized medicine, and increasing R&D activities in the pharmaceutical & biotechnology industry are contributing to market growth.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Electrosurgery Market by Product (Instruments, Accessories, Generators, Smoke Evacuation Systems), Surgery (Cardiovascular, Orthopedic, Cosmetic, Oncology, Urology, Neurosurgery), End User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2029
The global electrosurgery market, valued at US$6.5 billion in 2023, stood at US$6.9 billion in 2024 and is projected to advance at a resilient CAGR of 6.4% from 2024 to 2029, culminating in a forecasted valuation of US$9.4 billion by the end of the period. The market for electrosurgical instruments is experiencing robust growth, primarily fueled by the rising incidence of chronic diseases and the escalating demand for minimally invasive procedures.
- Published: May 2024
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
